Literature DB >> 2337548

Ultrastructural distribution of collagen types I-VI in aging human retinal vessels.

G E Marshall1, A G Konstas, W R Lee.   

Abstract

Retinal vessels from freshly enucleated human eyes were classified into three stages of the hyalinisation process. The distribution of collagen types I-VI within the vessel walls was studied ultrastructurally by immunogold labelling combined with the tissue preparation techniques of cryoultramicrotomy and London resin white embedding. Collagen types I, III, IV, V, and VI were found in large vessels, types I, IV, and V plus small amounts of III and VI in small vessels, and types I, IV, and V in capillaries. Hyalinised vessel walls consisted mainly of types I, IV, and VI collagen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2337548      PMCID: PMC1042067          DOI: 10.1136/bjo.74.4.228

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  The eye in general vascular disease: hypertension and arteriosclerosis.

Authors:  R LEISHMAN
Journal:  Br J Ophthalmol       Date:  1957-11       Impact factor: 4.638

2.  Ultrastructural location of extracellular matrix components in the optic nerve head.

Authors:  J C Morrison; N L L'Hernault; J A Jerdan; H A Quigley
Journal:  Arch Ophthalmol       Date:  1989-01

3.  Development of retinal neovascularisation in vascular occlusive disease.

Authors:  W A Manschot; W R Lee
Journal:  Trans Ophthalmol Soc U K       Date:  1985

Review 4.  Recent studies on the structure and pathology of basement membranes.

Authors:  D R Abrahamson
Journal:  J Pathol       Date:  1986-08       Impact factor: 7.996

5.  Retinal neovascularisation arising from hyalinised blood vessels.

Authors:  W A Manschot; W R Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1984       Impact factor: 3.117

6.  Immunogold quantitation of laminin, type IV collagen, and heparan sulfate proteoglycan in a variety of basement membranes.

Authors:  D S Grant; C P Leblond
Journal:  J Histochem Cytochem       Date:  1988-03       Impact factor: 2.479

7.  Collagen of brain microvessel preparations.

Authors:  B Faris; P Mozzicato; R Ferrera; M Glembourtt; P Toselli; C Franzblau
Journal:  Microvasc Res       Date:  1982-03       Impact factor: 3.514

8.  Actin, myosin, and laminin localization in retinal vessels of the rat.

Authors:  S R Gordon; E Essner
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

9.  Laminin detection in normal and retinitis pigmentosa human retina.

Authors:  D A Newsome; A T Hewitt
Journal:  Curr Eye Res       Date:  1985-09       Impact factor: 2.424

10.  Fibronectin and laminin distribution in bovine eye.

Authors:  T Kohno; N Sorgente; R Patterson; S J Ryan
Journal:  Jpn J Ophthalmol       Date:  1983       Impact factor: 2.447

View more
  6 in total

1.  Type IV collagen and laminin in Bruch's membrane and basal linear deposit in the human macula.

Authors:  G E Marshall; A G Konstas; G G Reid; J G Edwards; W R Lee
Journal:  Br J Ophthalmol       Date:  1992-10       Impact factor: 4.638

2.  Immunogold fine structural localization of extracellular matrix components in aged human cornea. II. Collagen types V and VI.

Authors:  G E Marshall; A G Konstas; W R Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

3.  Immunogold localisation of laminin in normal and exfoliative iris.

Authors:  A G Konstas; G E Marshall; W R Lee
Journal:  Br J Ophthalmol       Date:  1990-08       Impact factor: 4.638

4.  Collagens in the aged human macula.

Authors:  G E Marshall; A G Konstas; G G Reid; J G Edwards; W R Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-03       Impact factor: 3.117

Review 5.  Collagens in ocular tissues.

Authors:  G E Marshall; A G Konstas; W R Lee
Journal:  Br J Ophthalmol       Date:  1993-08       Impact factor: 4.638

6.  Immunogold study of non-collagenous matrix components in normal and exfoliative iris.

Authors:  A Vogiatzis; G E Marshall; A G Konstas; W R Lee
Journal:  Br J Ophthalmol       Date:  1994-11       Impact factor: 4.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.